<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-05T10:48:35Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/222896" metadataPrefix="rdf">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/222896</identifier><datestamp>2025-12-17T22:07:53Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478809</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:recercat.cat:2445/222896">
      <dc:title>Pharmaceutical Innovation Collaboration, Evaluation, and Matching</dc:title>
      <dc:creator>Liu, Qianshuo</dc:creator>
      <dc:subject>Gestió de la innovació</dc:subject>
      <dc:subject>Tecnologia farmacèutica</dc:subject>
      <dc:subject>Avaluació de l'assistència mèdica</dc:subject>
      <dc:subject>Innovation management</dc:subject>
      <dc:subject>Pharmaceutical technology</dc:subject>
      <dc:subject>Medical care evaluation</dc:subject>
      <dc:description>This paper theoretically studies pharmaceutical innovation collaborations, where heterogeneous firms compete for heterogeneous academics. At an interim stage, the firm evaluates the project, which allows it to monitor academics and decide whether to terminate the project to avoid the loss from a future failure. This paper explores the contract, project termination strategy, and collaboration matching. The firm’s innovation strategy (exploitations or explorations) determines the evaluation structure, which may affect the market equilibrium. (...)</dc:description>
      <dc:date>2025-09-02T11:30:46Z</dc:date>
      <dc:date>2025-09-02T11:30:46Z</dc:date>
      <dc:date>2024-12-01</dc:date>
      <dc:date>2025-09-02T11:30:46Z</dc:date>
      <dc:type>info:eu-repo/semantics/article</dc:type>
      <dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
      <dc:relation>Reproducció del document publicat a: https://doi.org/https://doi.org/10.1016/j.jhealeco.2024.102922</dc:relation>
      <dc:relation>Journal of Health Economics, 2024, vol. 98, p. 1-21</dc:relation>
      <dc:relation>https://doi.org/https://doi.org/10.1016/j.jhealeco.2024.102922</dc:relation>
      <dc:rights>cc-by-nc-nd (c) Elsevier B.V., 2024</dc:rights>
      <dc:rights>http://creativecommons.org/licenses/by-nd/3.0/es/</dc:rights>
      <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
      <dc:publisher>Elsevier B.V.</dc:publisher>
      <dc:source>Articles publicats en revistes (Economia)</dc:source>
   </ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>